IEIH

Fund Description
The Fund seeks to achieve its investment objective by investing, under normal circumstances, in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies, as defined by a proprietary classification system. The classification process, which uses data analysis tools consisting, in part, of machine learning, natural language processing ( NLP ) and clustering algorithms to allocate companies to one or more sectors according to a new classification system, is forward looking and evolves as companies evolve.
Fund Profile
Fund Name iShares Evolved U.S. Innovative Healthcare ETF
Fund Exchange Ticker IEIH
Fund Sponsor Blackrock (iShares)
Fund ISIN US46431W6223
Net Expense Ratio 0.18 %
Fund Inception Date 21 March 2018
Fund Legal Structure ETF (Open end fund)
Exchange BATS
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Active
Index Name Not Applicable
Index Provider Not Applicable
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 10 December 2018
Asset Under Management 5.03 Million (USD)
1 Month Total Return -2.58 %
Year To Date Return
1 Year Total Return
3 Year Annualized Total Return
NAV 25.15
Share Outstanding 200,000
Top 10 Holdings (7 December 2018)
Constituent Name Constituent Ticker Constituent Type Weighting
JOHNSON & JOHNSON JNJ EQUI 0.1088000000
PFIZER INC PFE EQUI 0.0775000000
MERCK & CO. INC. MRK EQUI 0.0714000000
ELI LILLY & CO LLY EQUI 0.0632000000
AMGEN INC AMGN EQUI 0.0525000000
BIOGEN INC BIIB EQUI 0.0476000000
ABBVIE INC ABBV EQUI 0.0464000000
GILEAD SCIENCES INC GILD EQUI 0.0440000000
VERTEX PHARMACEUTICALS INC VRTX EQUI 0.0436000000
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0407000000